In the News November 29, 2017

The Pink Sheet | Indication “Carve In” Allowed Under Generic Labeling “Carve-Out” Authority, US FDA Says

Marc Scheineson is quoted on a U.S. Food and Drug Administration decision allowing new language in abbreviated new drug applications.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement